(19)

(11)

EP 4 448 012 A1

(12)

(43) Date of publication: 23.10.2024 Bulletin 2024/43 (21) Application number: 22835699.4 (22) Date of filing: 12.12.2022

(51) International Patent Classification (IPC):  A61K 47/60(2017.01) A61P 19/08(2006.01) A61P 5/00(2006.01) (52) Cooperative Patent Classification (CPC): A61K 47/60; A61P 5/00; A61P 19/08 (86) International application number: PCT/EP2022/085414 (87) International publication number: WO 2023/110758 (22.06.2023 Gazette 2023/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 13.12.2021 EP 21214054 14.11.2022 EP 22207210 (71) Applicant: Ascendis Pharma Growth Disorders A/S 2900 Hellerup (DK)	(72) Inventors: SPROGØE, Kennett 2900 Hellerup (DK) KJELGAARD-HANSEN, Mads Jens 2900 Hellerup (DK) (74) Representative: Büchel, Edwin  Patentanwälte Isenbruck Bösl Hörschler PartG mbB Eastsite One Seckenheimer Landstraße 4 68163 Mannheim 68163 Mannheim (DE)